Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 92.17 USD 1.88%
Market Cap: 12.4B USD

Globus Medical Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Globus Medical Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Globus Medical Inc
NYSE:GMED
Net Income (Common)
$423.8m
CAGR 3-Years
40%
CAGR 5-Years
35%
CAGR 10-Years
15%
Becton Dickinson and Co
NYSE:BDX
Net Income (Common)
$1.7B
CAGR 3-Years
0%
CAGR 5-Years
17%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Net Income (Common)
$2.8B
CAGR 3-Years
67%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Income (Common)
$2.9B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Net Income (Common)
$14B
CAGR 3-Years
21%
CAGR 5-Years
33%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income (Common)
$2.7B
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
18%
No Stocks Found

Globus Medical Inc
Glance View

Globus Medical Inc., founded in 2003, has crafted a distinctive narrative in the landscape of medical technology, rooted in innovation and practicality. Emerging from a profound understanding of spinal pathologies, the company has steadily risen to become a pivotal player in the musculoskeletal sector. Its journey is steered by a commitment to addressing complex spine disorders through the development of cutting-edge products that are not only innovative but also substantially user-friendly for both surgeons and patients. This fusion of technology and practicality is what sets Globus Medical apart. The company relentlessly focuses on expanding its product offerings through significant investments in research and development, continuously pushing the envelope in areas such as minimally invasive surgery, advanced surgical approaches, and imaging, which form the core of its business operations. The heart of Globus Medical's revenue model lies in its expansive product portfolio that serves surgeons and healthcare institutions globally. Their financial engine is powered by the sales of implants and related surgical instruments, meticulously designed to improve surgical outcomes. These products span a wide array of offerings including but not limited to advanced minimally invasive techniques and sophisticated trauma solutions. Beyond the traditional revenue streams, Globus Medical has ventured into promising areas like robotic surgery, thereby augmenting its revenue sources while accessing the benefits of technological advancements. This strategic direction not only strengthens its market position but also ensures it stays at the forefront of providing value-based solutions in the ever-evolving healthcare landscape. By integrating its technological prowess with a deep understanding of clinical needs, Globus Medical continues to carve a robust path for sustainable growth and leadership in the medtech sector.

GMED Intrinsic Value
86.22 USD
Overvaluation 6%
Intrinsic Value
Price

See Also

What is Globus Medical Inc's Net Income (Common)?
Net Income (Common)
423.8m USD

Based on the financial report for Sep 30, 2025, Globus Medical Inc's Net Income (Common) amounts to 423.8m USD.

What is Globus Medical Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
15%

Over the last year, the Net Income (Common) growth was 363%. The average annual Net Income (Common) growth rates for Globus Medical Inc have been 40% over the past three years , 35% over the past five years , and 15% over the past ten years .

Back to Top